Profilo
Rick Kendall formerly worked at PYC Therapeutics Ltd., as Non-Executive Director in 2017, Amgen Australia Pty Ltd., as Executive Director-Oncology Research, and Kite Pharma, Inc., as Vice President-Research.
Precedenti posizioni note di Rick Kendall
| Società | Posizione | Fine |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 23/10/2017 |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Amgen Australia Pty Ltd. |
- Borsa valori
- Insiders
- Rick Kendall
